Tenet Healthcare (NYSE:THC) Price Target Raised to $155.00 at Deutsche Bank Aktiengesellschaft

Tenet Healthcare (NYSE:THC) had its price objective increased by Deutsche Bank Aktiengesellschaft from $150.00 to $155.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a buy rating on the stock.

Several other equities analysts also recently weighed in on the company. Baird R W upgraded Tenet Healthcare to a strong-buy rating in a research report on Thursday, May 30th. JPMorgan Chase & Co. increased their target price on shares of Tenet Healthcare from $107.00 to $140.00 and gave the stock an overweight rating in a report on Thursday, May 30th. Barclays lifted their price target on shares of Tenet Healthcare from $113.00 to $147.00 and gave the company an overweight rating in a report on Thursday, May 2nd. Cantor Fitzgerald restated an overweight rating and set a $104.00 price objective on shares of Tenet Healthcare in a research report on Wednesday, April 10th. Finally, Stephens increased their price target on Tenet Healthcare from $95.00 to $122.00 and gave the stock an equal weight rating in a research note on Wednesday, May 1st. One research analyst has rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of Buy and a consensus target price of $120.71.

Tenet Healthcare Stock Down 3.8 %

Tenet Healthcare stock opened at $133.03 on Friday. The stock has a market cap of $12.99 billion, a PE ratio of 5.16, a price-to-earnings-growth ratio of 1.40 and a beta of 2.12. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.37 and a current ratio of 1.44. The stock has a fifty day moving average of $127.08 and a 200 day moving average of $102.37. Tenet Healthcare has a one year low of $51.04 and a one year high of $142.35.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $3.22 earnings per share for the quarter, topping the consensus estimate of $1.45 by $1.77. Tenet Healthcare had a net margin of 12.53% and a return on equity of 26.76%. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.15 billion. During the same quarter in the prior year, the business earned $1.42 EPS. The business’s quarterly revenue was up 6.9% on a year-over-year basis. As a group, sell-side analysts predict that Tenet Healthcare will post 8.55 EPS for the current year.

Insiders Place Their Bets

In related news, Director Richard W. Fisher sold 2,500 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $123.20, for a total value of $308,000.00. Following the completion of the transaction, the director now owns 17,627 shares of the company’s stock, valued at approximately $2,171,646.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Richard W. Fisher sold 1,400 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $132.24, for a total value of $185,136.00. Following the completion of the sale, the director now owns 16,227 shares in the company, valued at approximately $2,145,858.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard W. Fisher sold 2,500 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $123.20, for a total transaction of $308,000.00. Following the transaction, the director now owns 17,627 shares in the company, valued at $2,171,646.40. The disclosure for this sale can be found here. Insiders sold 24,691 shares of company stock valued at $3,117,909 in the last three months. Corporate insiders own 0.93% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Tenet Healthcare by 0.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,604 shares of the company’s stock valued at $1,325,000 after acquiring an additional 90 shares during the period. Violich Capital Management Inc. grew its holdings in shares of Tenet Healthcare by 3.2% in the first quarter. Violich Capital Management Inc. now owns 3,380 shares of the company’s stock worth $355,000 after purchasing an additional 105 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Tenet Healthcare by 17.0% during the 1st quarter. GAMMA Investing LLC now owns 731 shares of the company’s stock valued at $77,000 after buying an additional 106 shares in the last quarter. Yousif Capital Management LLC grew its stake in Tenet Healthcare by 0.3% in the 4th quarter. Yousif Capital Management LLC now owns 42,825 shares of the company’s stock worth $3,236,000 after acquiring an additional 131 shares in the last quarter. Finally, SummerHaven Investment Management LLC raised its stake in shares of Tenet Healthcare by 1.7% during the fourth quarter. SummerHaven Investment Management LLC now owns 8,685 shares of the company’s stock valued at $656,000 after acquiring an additional 145 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.